These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1636779)

  • 1. Behavioral effects of A71623, a highly selective CCK-A agonist tetrapeptide.
    Asin KE; Bednarz L; Nikkel AL; Gore PA; Montana WE; Cullen MJ; Shiosaki K; Craig R; Nadzan AM
    Am J Physiol; 1992 Jul; 263(1 Pt 2):R125-35. PubMed ID: 1636779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of selective CCK receptor agonists on food intake after central or peripheral administration in rats.
    Asin KE; Gore PA; Bednarz L; Holladay M; Nadzan AM
    Brain Res; 1992 Jan; 571(1):169-74. PubMed ID: 1611492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraventricular CCK-8 reduces single meal size in the baboon by interaction with type-A CCK receptors.
    Figlewicz DP; Nadzan AM; Sipols AJ; Green PK; Liddle RA; Porte D; Woods SC
    Am J Physiol; 1992 Oct; 263(4 Pt 2):R863-7. PubMed ID: 1415799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety.
    Rex A; Barth T; Voigt JP; Domeney AM; Fink H
    Neurosci Lett; 1994 May; 172(1-2):139-42. PubMed ID: 8084519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A-71623, a selective CCK-A receptor agonist, suppresses food intake in the mouse, dog, and monkey.
    Asin KE; Bednarz L; Nikkel AL; Gore PA; Nadzan AM
    Pharmacol Biochem Behav; 1992 Aug; 42(4):699-704. PubMed ID: 1513850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversed behavioral effect of cholecystokinin after frontal decortication in rats.
    Itoh S; Katsuura G; Itoh T; Morimoto T
    Life Sci; 1994; 55(11):PL213-6. PubMed ID: 8072383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral effects of cholecystokinin and its related peptides in rats.
    Itoh S; Katsuura G
    Prog Clin Biol Res; 1985; 192():139-45. PubMed ID: 2934743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centrally administered CCK-8 suppresses activity in mice by a "peripheral-type" CCK receptor.
    Britton DR; Yahiro L; Cullen MJ; Kerwin JF; Kopecka H; Nadzan AM
    Pharmacol Biochem Behav; 1989 Dec; 34(4):779-83. PubMed ID: 2623030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of AR-R 15849, a highly selective CCK-A agonist.
    Simmons RD; Kaiser FC; Hudzik TJ
    Pharmacol Biochem Behav; 1999 Mar; 62(3):549-57. PubMed ID: 10080250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
    Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH
    Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sulfated cholecystokinin octapeptide and cholecystokinin tetrapeptide in rat behavior after blockade of nitric oxide synthase by L-NAME.
    Hoły Z; Wiśniewski K
    Rocz Akad Med Bialymst; 1998; 43():250-70. PubMed ID: 9972062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of nucleus accumbens to activities related to cholecystokinins in rats.
    Katsuura G; Itoh S; Hsiao S
    Peptides; 1985; 6(1):91-6. PubMed ID: 3991366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin tetrapeptide, proglumide and open-field behavior in rats.
    Hsiao S; Katsuura G; Itoh S
    Life Sci; 1984 May; 34(22):2165-8. PubMed ID: 6727557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal injections of nanogram CCK-8 doses inhibit feeding in rats.
    Canova A; Geary N
    Appetite; 1991 Dec; 17(3):221-7. PubMed ID: 1799284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of CCK-JMV-180 on food intake in rats and mice.
    Asin KE; Bednarz L
    Pharmacol Biochem Behav; 1992 Jun; 42(2):291-5. PubMed ID: 1631182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central effects of CCK ligands in pigs making operant responses for food.
    Parrott RF
    Pharmacol Biochem Behav; 1994 Nov; 49(3):463-9. PubMed ID: 7862695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary.
    Millington WR; Mueller GP; Lavigne GJ
    J Pharmacol Exp Ther; 1992 May; 261(2):454-61. PubMed ID: 1578360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic infusion of the amylin antagonist AC 187 increases feeding in Zucker fa/fa rats but not in lean controls.
    Grabler V; Lutz TA
    Physiol Behav; 2004 May; 81(3):481-8. PubMed ID: 15135020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
    Lin CW; Shiosaki K; Miller TR; Witte DG; Bianchi BR; Wolfram CA; Kopecka H; Craig R; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1991 Mar; 39(3):346-51. PubMed ID: 1706470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cholecystokinin (CCK-33) and its fragments, C-terminal octapeptide (CCK-8) and C-terminal tetrapeptide (CCK-4), on the circulatory system of diabetic rats.
    Fiedorowicz RJ; Wiśniewski K
    Pol J Pharmacol Pharm; 1989; 41(6):561-72. PubMed ID: 2485904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.